BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cozzolino M, Mangano M, Stucchi A, Ciceri P, Conte F, Galassi A. Cardiovascular disease in dialysis patients. Nephrol Dial Transplant 2018;33:iii28-34. [PMID: 30281132 DOI: 10.1093/ndt/gfy174] [Cited by in Crossref: 116] [Cited by in F6Publishing: 87] [Article Influence: 38.7] [Reference Citation Analysis]
Number Citing Articles
1 Martin KJ. How to Evaluate Phosphate Control in Patients on Dialysis. Nephrol Dial Transplant 2021:gfab205. [PMID: 34320212 DOI: 10.1093/ndt/gfab205] [Reference Citation Analysis]
2 Taheri S, Tavassoli-kafrani Z, Hosseini SM. Evaluation of the Correlation Between Cardiac Troponin I Versus Causes of Admission and In-Hospital Mortality in End-Stage Renal Disease Patients. Nephro-Urol Mon 2021;In Press. [DOI: 10.5812/numonthly.119304] [Reference Citation Analysis]
3 Okubo A, Doi T, Morii K, Nishizawa Y, Yamashita K, Shigemoto K, Mizuiri S, Usui K, Arita M, Naito T, Masaki T. Utility of CHA2DS2-VASc Score to Predict Mid-Term Clinical Outcomes in Hemodialysis Patients. Am J Nephrol 2022;:1-7. [PMID: 35259747 DOI: 10.1159/000522225] [Reference Citation Analysis]
4 Lai T, Hsu C, Lin M, Wu V, Chen Y. Trends in the incidence and prevalence of end-stage kidney disease requiring dialysis in Taiwan: 2010–2018. Journal of the Formosan Medical Association 2022. [DOI: 10.1016/j.jfma.2021.12.013] [Reference Citation Analysis]
5 Wang B, Wang GH, Ding XX, Tang HX, Zheng J, Liu BC, Zhang XL. Effects of Sacubitril/Valsartan on resistant hypertension and myocardial work in hemodialysis patients. J Clin Hypertens (Greenwich) 2022. [PMID: 35099841 DOI: 10.1111/jch.14422] [Reference Citation Analysis]
6 Ogata H, Fukagawa M, Hirakata H, Kagimura T, Fukushima M, Akizawa T; LANDMARK Investigators and Committees. Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis: The LANDMARK Randomized Clinical Trial. JAMA 2021;325:1946-54. [PMID: 34003226 DOI: 10.1001/jama.2021.4807] [Reference Citation Analysis]
7 Dellepiane S, Marengo M, D'Arezzo M, Donati G, Fabbrini P, Lacquaniti A, Ronco C, Cantaluppi V. The Next Evolution of HemoDialysis eXpanded: From a Delphi Questionnaire-Based Approach to the Real Life of Italian Dialysis Units. Blood Purif 2022;:1-10. [PMID: 35231902 DOI: 10.1159/000522038] [Reference Citation Analysis]
8 Anzaki K, Kanda D, Ikeda Y, Takumi T, Tokushige A, Ohmure K, Sonoda T, Arikawa R, Ohishi M. Impact of malnutrition on prognosis and coronary artery calcification in patients with stable coronary artery disease. Current Problems in Cardiology 2022. [DOI: 10.1016/j.cpcardiol.2022.101185] [Reference Citation Analysis]
9 Chen TY, Yang J, Zuo L, Wang L, Wang LF. Relationship of abdominal aortic calcification with lumbar vertebral volumetric bone mineral density assessed by quantitative computed tomography in maintenance hemodialysis patients. Arch Osteoporos 2022;17:24. [PMID: 35080671 DOI: 10.1007/s11657-022-01059-z] [Reference Citation Analysis]
10 Haase VH. Hypoxia-inducible factor-prolyl hydroxylase inhibitors in the treatment of anemia of chronic kidney disease. Kidney Int Suppl (2011) 2021;11:8-25. [PMID: 33777492 DOI: 10.1016/j.kisu.2020.12.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
11 Stepanova N, Driianska V, Korol L, Snisar L, Lebed L. Plasma oxalic acid and cardiovascular risk in end-stage renal disease patients: a prospective, observational cohort pilot study. Korean J Intern Med 2021. [PMID: 34167288 DOI: 10.3904/kjim.2020.561] [Reference Citation Analysis]
12 Borzou SR, Azami H, Gholyaf M, Tapak L, Nazari Doust T. The Effect of Preparing Dialysis Machine Using Normal Saline-Heparin on the Dialysis Adequacy of Hemodialysis Patients: A Crossover, Two-Group, and Randomized Clinical Trial. Nephro-Urol Mon 2021;13. [DOI: 10.5812/numonthly.112475] [Reference Citation Analysis]
13 Fang J, Su H, Song A, Tong Y, Huang Z, Ding F, Liu Y. Evaluation of inflammatory and cardiac-electrophysiological markers in patients undergoing peritoneal dialysis. Biomark Med 2020;14:1641-9. [PMID: 33336590 DOI: 10.2217/bmm-2020-0230] [Reference Citation Analysis]
14 Alshogran OY. Warfarin Dosing and Outcomes in Chronic Kidney Disease: A Closer Look at Warfarin Disposition. Curr Drug Metab 2019;20:633-45. [PMID: 31267868 DOI: 10.2174/1389200220666190701095807] [Reference Citation Analysis]
15 Wu P, Glerup RI, Svensson MHS, Eriksson N, Christensen JH, Laval PD, Soveri I, Westerlund M, Linde T, Ljunggren Ö, Fellström B. Novel Biomarkers Detected by Proteomics Predict Death and Cardiovascular Events in Hemodialysis Patients. Biomedicines 2022;10:740. [DOI: 10.3390/biomedicines10040740] [Reference Citation Analysis]
16 Wakasugi M, Nagai M, Yokota S, Omori K, Fujikawa H, Aoike I, Omori T, Kazama JJ, Narita I. The Association between Earlobe Creases and Cardiovascular Events in Japanese Hemodialysis Patients: A Prospective Cohort Study. Intern Med 2020;59:927-32. [PMID: 31839659 DOI: 10.2169/internalmedicine.3943-19] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Silva AP, Viegas CS, Mendes F, Macedo A, Guilherme P, Tavares N, Dias C, Rato F, Santos N, Faísca M, de Almeida E, Neves PL, Simes DC. Gla-Rich Protein (GRP) as an Early and Novel Marker of Vascular Calcification and Kidney Dysfunction in Diabetic Patients with CKD: A Pilot Cross-Sectional Study. J Clin Med 2020;9:E635. [PMID: 32120910 DOI: 10.3390/jcm9030635] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
18 Del Giorno R, Lavorato Hadjeres S, Stefanelli K, Allegra G, Zapparoli C, Predrag L, Berwert L, Gabutti L. Consequences of Supraphysiological Dialysate Magnesium on Arterial Stiffness, Hemodynamic Profile, and Endothelial Function in Hemodialysis: A Randomized Crossover Study Followed by a Non-Controlled Follow-Up Phase. Adv Ther 2020;37:4848-65. [PMID: 32996010 DOI: 10.1007/s12325-020-01505-9] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Rysz J, Franczyk B, Ławiński J, Gluba-Brzózka A. Oxidative Stress in ESRD Patients on Dialysis and the Risk of Cardiovascular Diseases. Antioxidants (Basel) 2020;9:E1079. [PMID: 33153174 DOI: 10.3390/antiox9111079] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
20 Radović N, Prelević V, Erceg M, Antunović T. Machine learning approach in mortality rate prediction for hemodialysis patients. Comput Methods Biomech Biomed Engin 2021;:1-12. [PMID: 34124977 DOI: 10.1080/10255842.2021.1937611] [Reference Citation Analysis]
21 Kaihan AB, Hishida M, Imaizumi T, Okazaki M, Kaihan AN, Katsuno T, Taguchi A, Yasuda Y, Tsuboi N, Kosugi T, Maruyama S. Circulating levels of CD34+ cells predict long-term cardiovascular outcomes in patients on maintenance hemodialysis. PLoS One 2019;14:e0223390. [PMID: 31584974 DOI: 10.1371/journal.pone.0223390] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Huang JC, Su HM, Wu PY, Lee JJ, Lee WH, Chen SC, Chiu YW, Hsu YL, Chang JM, Chen HC. Ratio of Early Mitral Inflow Velocity to the Global Diastolic Strain Rate and Global Left Ventricular Longitudinal Systolic Strain Predict Overall Mortality and Major Adverse Cardiovascular Events in Hemodialysis Patients. Dis Markers 2019;2019:7512805. [PMID: 31583030 DOI: 10.1155/2019/7512805] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
23 Choi SR, Lee YK, Cho Park H, Kim DH, Cho A, Kang MK, Choi S. Clinical significance of central systolic blood pressure in LV diastolic dysfunction and CV mortality. PLoS One 2021;16:e0250653. [PMID: 33951046 DOI: 10.1371/journal.pone.0250653] [Reference Citation Analysis]
24 Chung TL, Liu YH, Huang JC, Wu PY, Chen SC, Chang JM. Changes in acoustic cardiographic parameters before and after hemodialysis are associated with overall and cardiovascular mortality in hemodialysis patients. Sci Rep 2021;11:1559. [PMID: 33452428 DOI: 10.1038/s41598-021-81286-5] [Reference Citation Analysis]
25 Viegas C, Araújo N, Marreiros C, Simes D. The interplay between mineral metabolism, vascular calcification and inflammation in Chronic Kidney Disease (CKD): challenging old concepts with new facts. Aging (Albany NY) 2019;11:4274-99. [PMID: 31241466 DOI: 10.18632/aging.102046] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
26 Altunoren O, Kerkutluoglu M, Sarısık FN, Akkus G, Seyithanoglu M, Doganer A, Tutuncu Sezal D, Cagrı Aykan A, Eren N, Erken E, Gungor O. Can vasohibin-1, an endothelium-derived angiogenesis inhibitor, be a marker of endothelial dysfunction in hemodialysis patients? Semin Dial 2020;33:418-27. [PMID: 32686227 DOI: 10.1111/sdi.12899] [Reference Citation Analysis]
27 Ali OM, Sayed AA, Mohammed WS, Mohammed RR. Cardiovascular System Affection and Its Relation to First-Year Mortality in Patients Initiating Maintenance Hemodialysis. Int J Gen Med 2020;13:379-85. [PMID: 32753937 DOI: 10.2147/IJGM.S242549] [Reference Citation Analysis]
28 Zhou H, Chao W, Cui L, Li M, Zou Y, Yang M. Controlling Nutritional Status (CONUT) score as immune-nutritional predictor of outcomes in patients undergoing peritoneal dialysis. Clin Nutr 2020;39:2564-70. [PMID: 31787366 DOI: 10.1016/j.clnu.2019.11.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
29 Pinter J, Chazot C, Stuard S, Moissl U, Canaud B. Sodium, volume and pressure control in haemodialysis patients for improved cardiovascular outcomes. Nephrol Dial Transplant 2020;35:ii23-30. [PMID: 32162668 DOI: 10.1093/ndt/gfaa017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
30 Rabajdova M, Spakova I, Zelko A, Rosenberger J, Kolarcik P, Sobolova V, Pella D, Marekova M, Madarasova Geckova A. The role of physical activity and miRNAs in the vascular aging and cardiac health of dialysis patients. Physiol Rep 2021;9:e14879. [PMID: 34042291 DOI: 10.14814/phy2.14879] [Reference Citation Analysis]
31 Hsu HC, Robinson C, Woodiwiss AJ, Norton GR, Dessein PH. Cardiovascular Risk Factor Profiles and Disease in Black Compared to Other Africans with Chronic Kidney Disease. Int J Nephrol 2021;2021:8876363. [PMID: 33680512 DOI: 10.1155/2021/8876363] [Reference Citation Analysis]
32 Gupta R, Woo K, Yi JA. Epidemiology of end-stage kidney disease. Semin Vasc Surg 2021;34:71-8. [PMID: 33757639 DOI: 10.1053/j.semvascsurg.2021.02.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Voulgaris A, Bonsignore MR, Schiza S, Marrone O, Steiropoulos P. Is kidney a new organ target in patients with obstructive sleep apnea? Research priorities in a rapidly evolving field. Sleep Med 2021;86:56-67. [PMID: 34474225 DOI: 10.1016/j.sleep.2021.08.009] [Reference Citation Analysis]
34 Liu Q, Li S, Yu L, Feng J, Xue L, Lu G. The prognostic value of soluble Klotho in patients with haemodialysis: a systematic review and meta-analysis. Therapeutic Advances in Chronic Disease 2020;11:204062232094017. [DOI: 10.1177/2040622320940176] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Podestà MA, Cucchiari D, Ciceri P, Messa P, Torregrosa JV, Cozzolino M. Cardiovascular calcifications in kidney transplant recipients. Nephrol Dial Transplant 2021:gfab053. [PMID: 33620476 DOI: 10.1093/ndt/gfab053] [Reference Citation Analysis]
36 Raggi P, Bellasi A, Bushinsky D, Bover J, Rodriguez M, Ketteler M, Sinha S, Salcedo C, Gillotti K, Padgett C, Garg R, Gold A, Perelló J, Chertow GM. Slowing Progression of Cardiovascular Calcification With SNF472 in Patients on Hemodialysis: Results of a Randomized Phase 2b Study. Circulation 2020;141:728-39. [DOI: 10.1161/circulationaha.119.044195] [Cited by in Crossref: 43] [Cited by in F6Publishing: 27] [Article Influence: 21.5] [Reference Citation Analysis]
37 Pinar AA, Scott TE, Huuskes BM, Tapia Cáceres FE, Kemp-harper BK, Samuel CS. Targeting the NLRP3 inflammasome to treat cardiovascular fibrosis. Pharmacology & Therapeutics 2020;209:107511. [DOI: 10.1016/j.pharmthera.2020.107511] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 12.5] [Reference Citation Analysis]
38 Hildebrand S, Cunningham J. Is there a role for bisphosphonates in vascular calcification in chronic kidney disease? Bone 2021;142:115751. [PMID: 33188959 DOI: 10.1016/j.bone.2020.115751] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
39 Kim HY, Lee SJ, Hwang Y, Lee GH, Yoon CE, Kim HC, Yoo TH, Lee WW. Indoxyl Sulfate-Mediated Metabolic Alteration of Transcriptome Signatures in Monocytes of Patients with End-Stage Renal Disease (ESRD). Toxins (Basel) 2020;12:E621. [PMID: 32998431 DOI: 10.3390/toxins12100621] [Reference Citation Analysis]
40 Qi L, Ni X, Schoepf UJ, Varga-Szemes A, McGill L, Wang W, Zhang L, Luo S, Wen J, Zhang LJ. Time-dependent cardiac structural and functional changes after kidney transplantation: a multi-parametric cardiac magnetic resonance study. Eur Radiol 2022. [PMID: 35275257 DOI: 10.1007/s00330-022-08621-w] [Reference Citation Analysis]
41 Pazianas M, Miller PD. The CKD-MBD Syndrome: Hysteresis in PTH Involvement and PTH Administration for Its Management. J Bone Miner Res 2020;35:2313-7. [PMID: 32780482 DOI: 10.1002/jbmr.4155] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Scheuermann U, Rademacher S, Jahn N, Sucher E, Seehofer D, Sucher R, Hau HM. Impact of pre-transplant dialysis modality on the outcome and health-related quality of life of patients after simultaneous pancreas-kidney transplantation. Health Qual Life Outcomes 2020;18:303. [PMID: 32912255 DOI: 10.1186/s12955-020-01545-3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
43 Lu X, Zhang J, Wang S, Yu Q, Li H. High Erythropoiesis Resistance Index Is a Significant Predictor of Cardiovascular and All-Cause Mortality in Chinese Maintenance Hemodialysis Patients. Mediators Inflamm 2020;2020:1027230. [PMID: 33293895 DOI: 10.1155/2020/1027230] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Frezin J, Navez J, Johnson P, Bouchard P, Drolet S. Colorectal resection in end-stage renal disease (ESRD) patients: experience from a single tertiary center. Acta Chir Belg 2021;:1-10. [PMID: 33496207 DOI: 10.1080/00015458.2020.1871290] [Reference Citation Analysis]
45 Morooka H, Tanaka A, Inaguma D, Maruyama S. Peripheral artery disease at the time of dialysis initiation and mortality: a prospective observational multicenter study. BMJ Open 2020;10:e042315. [PMID: 33384396 DOI: 10.1136/bmjopen-2020-042315] [Reference Citation Analysis]
46 Rijkse E, Qi H, Babakry S, Bijdevaate DC, Kimenai HJAN, Roodnat JI, IJzermans JNM, Minnee RC. To screen or not to screen? The development of a prediction model for aorto-iliac stenosis in kidney transplant candidates. Transpl Int 2021;34:2371-81. [PMID: 34416037 DOI: 10.1111/tri.14013] [Reference Citation Analysis]
47 Stranavova L, Hruba P, Slatinska J, Sawitzki B, Reinke P, Volk HD, Viklicky O. Dialysis therapy is associated with peripheral marginal zone B-cell augmentation. Transpl Immunol 2020;60:101289. [PMID: 32229239 DOI: 10.1016/j.trim.2020.101289] [Reference Citation Analysis]
48 Silva RE, Santos EC, Justino PBI, Santos MP, Galdino G, Gonçalves RV, Novaes RD. Cytokines and chemokines systemic levels are related to dialysis adequacy and creatinine clearance in patients with end-stage renal disease undergoing hemodialysis. Int Immunopharmacol 2021;100:108154. [PMID: 34555645 DOI: 10.1016/j.intimp.2021.108154] [Reference Citation Analysis]
49 Grazioli E, Romani A, Marrone G, Di Lauro M, Cerulli C, Urciuoli S, Murri A, Guerriero C, Tranchita E, Tesauro M, Parisi A, Di Daniele N, Noce A. Impact of Physical Activity and Natural Bioactive Compounds on Endothelial Dysfunction in Chronic Kidney Disease. Life (Basel) 2021;11:841. [PMID: 34440585 DOI: 10.3390/life11080841] [Reference Citation Analysis]
50 Fishbane SN, Nigwekar S. Phosphate Absorption and Hyperphosphatemia Management in Kidney Disease: A Physiology-Based Review. Kidney Med 2021;3:1057-64. [PMID: 34939015 DOI: 10.1016/j.xkme.2021.07.003] [Reference Citation Analysis]
51 Westphalen H, Abdelrasoul A, Shoker A. Protein adsorption phenomena in hemodialysis membranes: Mechanisms, influences of clinical practices, modeling, and challenges. Colloid and Interface Science Communications 2021;40:100348. [DOI: 10.1016/j.colcom.2020.100348] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
52 Opdebeeck B, D'Haese PC, Verhulst A. Molecular and Cellular Mechanisms that Induce Arterial Calcification by Indoxyl Sulfate and P-Cresyl Sulfate. Toxins (Basel) 2020;12:E58. [PMID: 31963891 DOI: 10.3390/toxins12010058] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
53 Lee YH, Kim JS, Jung SW, Hwang HS, Moon JY, Jeong KH, Lee SH, Lee SY, Ko GJ, Lee DY, Lee HJ, Kim YG. Gait speed and handgrip strength as predictors of all-cause mortality and cardiovascular events in hemodialysis patients. BMC Nephrol 2020;21:166. [PMID: 32375664 DOI: 10.1186/s12882-020-01831-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
54 Roetker NS, Guo H, Ramey, Abd DR, Mcmullan CJ, Atkins GB, Wetmore JB. Hemodialysis Vascular Access and Risk of Major Bleeding, Thrombosis, and Cardiovascular Events: A Cohort Study. Kidney Medicine 2022. [DOI: 10.1016/j.xkme.2022.100456] [Reference Citation Analysis]
55 Sinha S, Raggi P, Chertow GM. SNF472: mechanism of action and results from clinical trials. Curr Opin Nephrol Hypertens 2021;30:424-9. [PMID: 34027904 DOI: 10.1097/MNH.0000000000000726] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Zhang F, Wang H, Wang W, Zhang H. The Role of Physical Activity and Mortality in Hemodialysis Patients: A Review. Front Public Health 2022;10:818921. [DOI: 10.3389/fpubh.2022.818921] [Reference Citation Analysis]
57 Ljubičić J, Pešić A, Marinković N, Kravljača M. Prevalence and risk factors for coronary artery disease in patients on chronic hemodialysis. Medicinski podmladak 2021;72:34-9. [DOI: 10.5937/mp72-34597] [Reference Citation Analysis]
58 Zhu X, Cai H, Zhu M, Zhan Y, Che M, Lin X, Zhang W, Ni Z. Association of abdominal aortic calcification estimated by plain radiography with outcomes in haemodialysis patients: A 6-year follow-up study. Nephrology (Carlton) 2020;25:559-65. [PMID: 31424612 DOI: 10.1111/nep.13644] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
59 Lin CJ, Chien MH, Yang MJ, Lin MH, Hsu CC, Chu PL. Trends of medication used in patients with pre-ESKD from 2010 to 2018 in Taiwan. J Formos Med Assoc 2021:S0929-6646(21)00577-5. [PMID: 34980550 DOI: 10.1016/j.jfma.2021.12.012] [Reference Citation Analysis]
60 Olczyk P, Małyszczak A, Gołębiowski T, Letachowicz K, Szymczak A, Mazanowska O, Krajewska M, Kusztal M. Arterial Stiffness Assessed by Oscillometric Method in Kidney Transplant, Predialysis, and Dialysis Patients. Transplant Proc 2020;52:2337-40. [PMID: 32359829 DOI: 10.1016/j.transproceed.2020.01.132] [Reference Citation Analysis]
61 Mccullough PA. Anemia of cardiorenal syndrome. Kidney International Supplements 2021;11:35-45. [DOI: 10.1016/j.kisu.2020.12.001] [Reference Citation Analysis]
62 Lai AC, Bienstock SW, Sharma R, Skorecki K, Beerkens F, Samtani R, Coyle A, Kim T, Baber U, Camaj A, Power D, Fuster V, Goldman ME. A Personalized Approach to Chronic Kidney Disease and Cardiovascular Disease: JACC Review Topic of the Week. J Am Coll Cardiol 2021;77:1470-9. [PMID: 33736830 DOI: 10.1016/j.jacc.2021.01.028] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
63 Antić S, Draginić N, Nikolić T, Jeremić N, Petrović D. Oxidative Stress in Hemodialysis Patients: Pathophysiological Mechanisms, Clinical Consequences and Basic Principles of Treatment. Serbian Journal of Experimental and Clinical Research 2019;0:000010247820190008. [DOI: 10.2478/sjecr-2019-0008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 Rysz J, Gluba-Brzózka A, Rysz-Górzyńska M, Franczyk B. The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular Disease. Int J Mol Sci 2020;21:E601. [PMID: 31963445 DOI: 10.3390/ijms21020601] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
65 Sprague SM, Martin KJ, Coyne DW. Phosphate Balance and CKD-Mineral Bone Disease. Kidney Int Rep 2021;6:2049-58. [PMID: 34386654 DOI: 10.1016/j.ekir.2021.05.012] [Reference Citation Analysis]
66 Wu PH, Lin YT, Chiu YW, Baldanzi G, Huang JC, Liang SS, Lee SC, Chen SC, Hsu YL, Kuo MC, Hwang SJ. The relationship of indoxyl sulfate and p-cresyl sulfate with target cardiovascular proteins in hemodialysis patients. Sci Rep 2021;11:3786. [PMID: 33589722 DOI: 10.1038/s41598-021-83383-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
67 Hung T, Wu S, Chiou J, Wang Y, Liao Y, Wei C. Association of Permanent Vascular Access Dysfunction with Subsequent Risk of Cardiovascular Disease: A Population-Based Cohort Study. JPM 2022;12:598. [DOI: 10.3390/jpm12040598] [Reference Citation Analysis]
68 Navarro-García JA, Rodríguez-Sánchez E, Aceves-Ripoll J, Abarca-Zabalía J, Susmozas-Sánchez A, González Lafuente L, Bada-Bosch T, Hernández E, Mérida-Herrero E, Praga M, Ruilope LM, Ruiz-Hurtado G. Oxidative Status before and after Renal Replacement Therapy: Differences between Conventional High Flux Hemodialysis and on-Line Hemodiafiltration. Nutrients 2019;11:E2809. [PMID: 31744232 DOI: 10.3390/nu11112809] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
69 Hartzell S, Bin S, Cantarelli C, Haverly M, Manrique J, Angeletti A, Manna G, Murphy B, Zhang W, Levitsky J, Gallon L, Yu SM, Cravedi P. Kidney Failure Associates With T Cell Exhaustion and Imbalanced Follicular Helper T Cells. Front Immunol 2020;11:583702. [PMID: 33117396 DOI: 10.3389/fimmu.2020.583702] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
70 Eikelboom J, Floege J, Thadhani R, Weitz JI, Winkelmayer WC. Anticoagulation in patients with kidney failure on dialysis: factor XI as a therapeutic target. Kidney Int 2021;100:1199-207. [PMID: 34600964 DOI: 10.1016/j.kint.2021.08.028] [Reference Citation Analysis]
71 Schoutteten MK, Vranken J, Lee S, Smeets CJP, De Cannière H, Van Hoof C, Peeters J, Groenendaal W, Vandervoort PM. Towards personalized fluid monitoring in haemodialysis patients: thoracic bioimpedance signal shows strong correlation with fluid changes, a cohort study. BMC Nephrol 2020;21:264. [PMID: 32652949 DOI: 10.1186/s12882-020-01922-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Kayali F, Sarodaya V, Shah HI, Hayat MY, Leung MST, Harky A. Predicting outcomes of mesenteric ischemia postcardiac surgery: A systematic review. J Card Surg 2022. [PMID: 35488799 DOI: 10.1111/jocs.16516] [Reference Citation Analysis]
73 Zhang F, Wang H, Huang L, Bai Y. Physical Activity and Mortality in Patients With Chronic Kidney Disease: A Protocol for Systematic Review and Dose-Response Meta-Analysis. Front Med 2022;9:861013. [DOI: 10.3389/fmed.2022.861013] [Reference Citation Analysis]
74 Su WY, Chu NS, Huang JC, Wu PY, Lee WH, Liu YH, Chen SC, Su HM. Low Albumin, Low Bilirubin, and High Alfa-Fetoprotein Are Associated with a Rapid Renal Function Decline in a Large Population Follow-Up Study. J Pers Med 2021;11:781. [PMID: 34442425 DOI: 10.3390/jpm11080781] [Reference Citation Analysis]
75 Gadaen RJR, Kooman JP, Cornelis T, van der Sande FM, Winkens BJ, Broers NJH. The Effects of Chronic Dialysis on Physical Status, Quality of Life, and Arterial Stiffness: A Longitudinal Study in Prevalent Dialysis Patients. Nephron 2021;145:44-54. [PMID: 33108785 DOI: 10.1159/000510624] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
76 Cohen G. Immune Dysfunction in Uremia 2020. Toxins (Basel) 2020;12:E439. [PMID: 32635646 DOI: 10.3390/toxins12070439] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
77 Malgaj Vrečko M, Ponikvar R, Gubenšek J, Buturović Ponikvar J. Clinical and dialysis-related characteristics of extremely long-term hemodialysis survivors: Three case reports. Hemodial Int 2021. [PMID: 33749104 DOI: 10.1111/hdi.12925] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
78 Voicehovska JG, Bormane E, Grigane A, Moisejevs G, Moreino E, Trumpika D, Voicehovskis VV. Association of Arterial Stiffness With Chronic Kidney Disease Progression and Mortality. Heart Lung Circ 2021;30:1694-701. [PMID: 34503918 DOI: 10.1016/j.hlc.2021.08.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Lim WH, Johnson DW, McDonald SP, Hawley C, Clayton PA, Jose MD, Wong G. Impending challenges of the burden of end-stage kidney disease in Australia. Med J Aust 2019;211:374-380.e3. [PMID: 31595516 DOI: 10.5694/mja2.50354] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
80 Pojatić Đ, Tolj I, Pezerović D, Degmečić D. Systematic Review of Alexithymia in the Population of Hemodialysis Patients. J Clin Med 2021;10:2862. [PMID: 34203282 DOI: 10.3390/jcm10132862] [Reference Citation Analysis]
81 Karimi Galougahi K, Chadban S, Mehran R, Bangalore S, Chertow GM, Ali ZA. Invasive Management of Coronary Artery Disease in Advanced Renal Disease. Kidney Int Rep 2021;6:1513-24. [PMID: 34169192 DOI: 10.1016/j.ekir.2021.02.041] [Reference Citation Analysis]
82 Su G, Saglimbene V, Wong G, Natale P, Ruospo M, Craig JC, Hegbrant J, Carrero JJ, Strippoli GFM. Healthy Lifestyle and Mortality Among Adults Receiving Hemodialysis: The DIET-HD Study. Am J Kidney Dis 2021:S0272-6386(21)00875-1. [PMID: 34547395 DOI: 10.1053/j.ajkd.2021.07.022] [Reference Citation Analysis]
83 Nimmo A, Forsyth JL, Oniscu GC, Robb M, Watson C, Fotheringham J, Roderick PJ, Ravanan R, Taylor DM. A propensity score-matched analysis indicates screening for asymptomatic coronary artery disease does not predict cardiac events in kidney transplant recipients. Kidney Int 2021;99:431-42. [PMID: 33171171 DOI: 10.1016/j.kint.2020.10.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
84 Birdwell KA, Park M. Post-Transplant Cardiovascular Disease. Clin J Am Soc Nephrol 2021:CJN. [PMID: 34556500 DOI: 10.2215/CJN.00520121] [Reference Citation Analysis]
85 Lydia A, Yassir Y, Hidayat R, Suwarto S. The Association Between Uric Acid and Symmetric Dimethylarginine Levels in the Patients Undergoing Twice-weekly Hemodialysis. Nephro-Urol Mon 2021;13. [DOI: 10.5812/numonthly.117476] [Reference Citation Analysis]
86 Ciceri P, Cozzolino M. Expanded Haemodialysis as a Current Strategy to Remove Uremic Toxins. Toxins (Basel) 2021;13:380. [PMID: 34073439 DOI: 10.3390/toxins13060380] [Reference Citation Analysis]
87 Kanda E, Epureanu BI, Adachi T, Tsuruta Y, Kikuchi K, Kashihara N, Abe M, Masakane I, Nitta K. Application of explainable ensemble artificial intelligence model to categorization of hemodialysis-patient and treatment using nationwide-real-world data in Japan. PLoS One 2020;15:e0233491. [PMID: 32469924 DOI: 10.1371/journal.pone.0233491] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
88 Ferrari F, Helal L, Dipp T, Soares D, Soldatelli Â, Mills AL, Paz C, Tenório MCC, Motta MT, Barcellos FC, Stein R. Intradialytic training in patients with end-stage renal disease: a systematic review and meta-analysis of randomized clinical trials assessing the effects of five different training interventions. J Nephrol 2020;33:251-66. [PMID: 31865607 DOI: 10.1007/s40620-019-00687-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
89 Iseri K, Qureshi AR, Dai L, Ripsweden J, Heimbürger O, Barany P, Bergström I, Stenvinkel P, Brismar TB, Lindholm B. Bone mineral density at different sites and 5 years mortality in end-stage renal disease patients: A cohort study. Bone 2020;130:115075. [PMID: 31669253 DOI: 10.1016/j.bone.2019.115075] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
90 van Zonneveld AJ, Kölling M, Bijkerk R, Lorenzen JM. Circular RNAs in kidney disease and cancer. Nat Rev Nephrol 2021. [PMID: 34381199 DOI: 10.1038/s41581-021-00465-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 Nelson AJ, Raggi P, Wolf M, Gold AM, Chertow GM, Roe MT. Targeting Vascular Calcification in Chronic Kidney Disease. JACC Basic Transl Sci 2020;5:398-412. [PMID: 32368697 DOI: 10.1016/j.jacbts.2020.02.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 11.5] [Reference Citation Analysis]
92 Takic M, Zekovic M, Terzic B, Stojsavljevic A, Mijuskovic M, Radjen S, Ristic-Medic D. Zinc Deficiency, Plasma Fatty Acid Profile and Desaturase Activities in Hemodialysis Patients: Is Supplementation Necessary? Front Nutr 2021;8:700450. [PMID: 34631763 DOI: 10.3389/fnut.2021.700450] [Reference Citation Analysis]
93 Wu PH, Lin YT, Wu PY, Lee HH, Lee SC, Hung SC, Chen SC, Kuo MC, Chiu YW. Association between Circulation Indole-3-Acetic Acid Levels and Stem Cell Factor in Maintenance Hemodialysis Patients: A Cross-Sectional Study. J Clin Med 2020;9:E124. [PMID: 31906560 DOI: 10.3390/jcm9010124] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
94 Podestà MA, Valli F, Galassi A, Cassia MA, Ciceri P, Barbieri L, Carugo S, Cozzolino M. The Impact of Old and Novel Cardiovascular Risk Factors. Blood Purif 2021;:1-10. [PMID: 33752209 DOI: 10.1159/000514467] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Gwozdzinski K, Pieniazek A, Gwozdzinski L. Reactive Oxygen Species and Their Involvement in Red Blood Cell Damage in Chronic Kidney Disease. Oxid Med Cell Longev 2021;2021:6639199. [PMID: 33708334 DOI: 10.1155/2021/6639199] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
96 de Gonzalo-Calvo D, Martínez-Camblor P, Bär C, Duarte K, Girerd N, Fellström B, Schmieder RE, Jardine AG, Massy ZA, Holdaas H, Rossignol P, Zannad F, Thum T. Improved cardiovascular risk prediction in patients with end-stage renal disease on hemodialysis using machine learning modeling and circulating microribonucleic acids. Theranostics 2020;10:8665-76. [PMID: 32754270 DOI: 10.7150/thno.46123] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
97 Rodríguez-Sánchez E, Navarro-García JA, Aceves-Ripoll J, Abarca-Zabalía J, Susmozas-Sánchez A, Bada-Bosch T, Hernández E, Mérida-Herrero E, Andrés A, Praga M, Fernández-Ruiz M, Aguado JM, Segura J, Ruilope LM, Ruiz-Hurtado G. Variations in Circulating Active MMP-9 Levels During Renal Replacement Therapy. Biomolecules 2020;10:E505. [PMID: 32225016 DOI: 10.3390/biom10040505] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
98 Chang JF, Wu CC, Hsieh CY, Li YY, Wang TM, Liou JC. A Joint Evaluation of Impaired Cardiac Sympathetic Responses and Malnutrition-Inflammation Cachexia for Mortality Risks in Hemodialysis Patients. Front Med (Lausanne) 2020;7:99. [PMID: 32292788 DOI: 10.3389/fmed.2020.00099] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
99 Chang YC, Wang CH, Lai YH, Lin YL, Kuo CH, Hsu BG, Tsai JP. Low serum 3-methyl histidine level is associated with aortic stiffness in maintenance hemodialysis patients. Ther Apher Dial 2021. [PMID: 34748283 DOI: 10.1111/1744-9987.13754] [Reference Citation Analysis]
100 Singh AT, Mothi SS, Li P, Sabbisetti V, Waikar SS, Mc Causland FR. Endothelin-1 and Parameters of Systolic Blood Pressure in Hemodialysis. Am J Hypertens 2021:hpab104. [PMID: 34192305 DOI: 10.1093/ajh/hpab104] [Reference Citation Analysis]
101 Chisavu LA, Apostol A, Pop GN, Ivan V, Schiller O, Bob F, Marc L, Mihaescu A, Gadalean F, Grosu I, Timar B, Schiller A. Exploring the relation between mortality and left ventricular structure and function in stable hemodialysis treated patients, a longitudinal multicenter cohort study. Sci Rep 2021;11:12694. [PMID: 34135351 DOI: 10.1038/s41598-021-91431-9] [Reference Citation Analysis]
102 Li YS, Wang SH, Hwang SJ, Yang YH, Hsieh KP. Comparison of effectiveness and safety between ticagrelor and clopidogrel in patients with acute coronary syndrome and on dialysis in Taiwan. Br J Clin Pharmacol 2021. [PMID: 34080719 DOI: 10.1111/bcp.14935] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
103 Varikasuvu SR, Sulekar H, Aloori S, Thangappazham B. The association of non-invasive skin autofluorescence measurements with cardiovascular and all-cause mortality in hemodialysis patients: a meta-analysis. Int Urol Nephrol 2020;52:1757-69. [PMID: 32661621 DOI: 10.1007/s11255-020-02543-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
104 Cozzolino M, Magagnoli L, Ciceri P, Conte F, Galassi A. Effects of a medium cut-off (Theranova®) dialyser on haemodialysis patients: a prospective, cross-over study. Clin Kidney J 2021;14:382-9. [PMID: 33564442 DOI: 10.1093/ckj/sfz155] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
105 Pazianas M, Miller PD. Current Understanding of Mineral and Bone Disorders of Chronic Kidney Disease and the Scientific Grounds on the Use of Exogenous Parathyroid Hormone in Its Management. J Bone Metab 2020;27:1-13. [PMID: 32190604 DOI: 10.11005/jbm.2020.27.1.1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
106 Sharma S, Hanudel MR, Ix JH, Salusky IB, Ganz T, Nguyen KL. Elevated Fibroblast Growth Factor 23 Levels Are Associated With Greater Diastolic Dysfunction in ESRD. Kidney Int Rep 2019;4:1748-51. [PMID: 31844812 DOI: 10.1016/j.ekir.2019.07.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
107 Hsu G, Sparkes TM, Reed BN, Gale SE, Crossley BE, Ravichandran BR. The Impact of Atherosclerotic Cardiovascular Risk on Graft Failure in Deceased-Donor Renal Transplantation. Prog Transplant 2021;31:201-10. [PMID: 34132149 DOI: 10.1177/15269248211024610] [Reference Citation Analysis]
108 Sasakawa Y, Okamoto N, Fujii M, Kato J, Yuzawa Y, Inaguma D. Factors associated with aortic valve stenosis in Japanese patients with end-stage kidney disease. BMC Nephrol 2022;23. [DOI: 10.1186/s12882-022-02758-y] [Reference Citation Analysis]
109 Cardoso A, Branco C, Sant'Ana M, Costa C, Silva B, Fonseca J, Outerelo C, Gameiro J. Hypoalbuminaemia and One-Year Mortality in Haemodialysis Patients with Heart Failure: A Cohort Analysis. J Clin Med 2021;10:4518. [PMID: 34640538 DOI: 10.3390/jcm10194518] [Reference Citation Analysis]
110 Boden WE, Baum S, Toth PP, Fazio S, Bhatt DL. Impact of expanded FDA indication for icosapent ethyl on enhanced cardiovascular residual risk reduction. Future Cardiol 2021;17:155-74. [PMID: 32959713 DOI: 10.2217/fca-2020-0106] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
111 Sanghani NS, Haase VH. Hypoxia-Inducible Factor Activators in Renal Anemia: Current Clinical Experience. Adv Chronic Kidney Dis 2019;26:253-66. [PMID: 31477256 DOI: 10.1053/j.ackd.2019.04.004] [Cited by in Crossref: 63] [Cited by in F6Publishing: 52] [Article Influence: 31.5] [Reference Citation Analysis]
112 Alrais M, Thomas D, Abdolmonem H, Zachariah S, Jagdale R, Baker D. On the Relationship Between Cardiovascular Risk Marker Calcium Phosphate Product and Health-Related Quality of Life in Hemodialysis Patients. Nephro-Urol Mon 2022;In Press. [DOI: 10.5812/numonthly-121520] [Reference Citation Analysis]
113 Antic S, Draginic N, Jovanovic M, Nikolic T, Jeremic N, Živkovic V, Srejovic I, Petrovic D, Jakovljevic V. Relation Between Oxidative Stress and Carotid Artery Atherosclerosis in Hemodyalisis Patients. Serbian Journal of Experimental and Clinical Research 2019;0:000010247820190052. [DOI: 10.2478/sjecr-2019-0052] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
114 Hashiba T, Tanaka M, Honda T, Kishi S, Ogura Y, Takenaka Y, Furuse S, Nishio K, Masaki K, Kano T, Mise N. Aortic arch calcification affects causes of death in patients on hemodialysis: a retrospective cohort study. Ren Replace Ther 2022;8. [DOI: 10.1186/s41100-022-00394-8] [Reference Citation Analysis]
115 Deligiannis A, D'Alessandro C, Cupisti A. Exercise training in dialysis patients: impact on cardiovascular and skeletal muscle health. Clin Kidney J 2021;14:ii25-33. [PMID: 33981417 DOI: 10.1093/ckj/sfaa273] [Reference Citation Analysis]
116 Liu P, Wu J, Wang L, Han D, Sun C, Sun J. The prevalence of fragmented QRS and its relationship with left ventricular systolic function in chronic kidney disease. J Int Med Res 2020;48:300060519890792. [PMID: 31872784 DOI: 10.1177/0300060519890792] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
117 Sotomayor CG, Te Velde-Keyzer CA, de Borst MH, Navis GJ, Bakker SJL. Lifestyle, Inflammation, and Vascular Calcification in Kidney Transplant Recipients: Perspectives on Long-Term Outcomes. J Clin Med 2020;9:E1911. [PMID: 32570920 DOI: 10.3390/jcm9061911] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
118 Cai H, Zhu X, Lu J, Zhu M, Liu S, Zhan Y, Ni Z, Gu L, Zhang W, Mou S. A Decreased Level of Soluble Klotho Can Predict Cardiovascular Death in No or Mild Abdominal Aortic Calcification Hemodialysis Patients. Front Med (Lausanne) 2021;8:672000. [PMID: 34079811 DOI: 10.3389/fmed.2021.672000] [Reference Citation Analysis]
119 Luo D, Zhao W, Lin Z, Wu J, Lin H, Li Y, Song J, Zhang J, Peng H. The Effects of Hemodialysis and Peritoneal Dialysis on the Gut Microbiota of End-Stage Renal Disease Patients, and the Relationship Between Gut Microbiota and Patient Prognoses. Front Cell Infect Microbiol 2021;11:579386. [PMID: 33834002 DOI: 10.3389/fcimb.2021.579386] [Reference Citation Analysis]
120 Sharif A. The Argument for Abolishing Cardiac Screening of Asymptomatic Kidney Transplant Candidates. American Journal of Kidney Diseases 2020;75:946-54. [DOI: 10.1053/j.ajkd.2019.05.033] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
121 Ahmad HA, Thomas D, Alrais M, Burton A, Jagdale R. Shortcoming of Measuring Patient Satisfaction's Association With Anemia-Based Cardiovascular Risk in End-Stage Kidney Disease Patients. Cardiol Res 2021;12:344-50. [PMID: 34970364 DOI: 10.14740/cr1332] [Reference Citation Analysis]
122 Vida C, Carracedo J, Sequera P, Bodega G, Pérez R, Alique M, Ramírez R. Increasing the Magnesium Concentration in Various Dialysate Solutions Differentially Modulates Oxidative Stress in a Human Monocyte Cell Line. Antioxidants (Basel) 2020;9:E319. [PMID: 32326605 DOI: 10.3390/antiox9040319] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
123 Kim DK, Lee YH, Kim JS, Kim YG, Lee SY, Ahn SY, Lee DY, Jeong KH, Lee SH, Hwang HS, Moon JY. Circulating Vascular Adhesion Protein-1 Level Predicts the Risk of Cardiovascular Events and Mortality in Hemodialysis Patients. Front Cardiovasc Med 2021;8:701079. [PMID: 34557529 DOI: 10.3389/fcvm.2021.701079] [Reference Citation Analysis]
124 Fusaro M, Cozzolino M, Plebani M, Iervasi G, Ketteler M, Gallieni M, Aghi A, Locatelli F, Cunningham J, Salam S, Zaninotto M, Ravera M, Russo D, Mereu MC, Giannini S, Brandi ML, Ferrari S, Sella S, Egan CG, Bellasi A, Di Lullo L, Tripepi G, Nickolas T. Sevelamer Use, Vitamin K Levels, Vascular Calcifications, and Vertebral Fractures in Hemodialysis Patients: Results from the VIKI Study. J Bone Miner Res 2021;36:500-9. [PMID: 33188702 DOI: 10.1002/jbmr.4214] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]